Hello, we’re Neuropad®

We help your feet stay healthy through early screening for diabetic foot syndrome and clinically proven treatment.

Test for diabetic foot issues with our screening test and protect against cracking with our foot foam, especially formulated for people with diabetes.

Neuropad screening test, with packaging

Why Neuropad®?

Diabetic foot ulcers and amputations are serious complications of poorly controlled diabetes, often caused by peripheral neuropathy — a condition that affects about half of all people with diabetes.

Worryingly, according to Diabetes UK, over 30% of people with diabetes aren’t even aware that foot problems are a common complication.

The Neuropad® 10-Minute Screening Test® can help in the early identification of diabetes-related foot problems.

Smiley feet

Early neuropathy impacts sweat control

Our screening test detects damage to the sudomotor (or sweating) function, which is one of the first signs of diabetic neuropathy, as small nerve fibres are impacted.

Complications may develop before treatment starts

Early identification of possible problems via the Neuropad® 10-minute screening test® is a huge advantage.

Early warning system

Think of the test as an early warning system for your feet, helping to diagnose neuropathy before more serious condtions develop.

Where to get Neuropad®

You can buy Neuropad® 10-Minute Screening Test® and Neuropad® Foot Foam from our online store.

An introduction to Neuropad® for people with diabetes

How the 10-Minute Neuropad® Screening Test works

How to use and apply a Neuropad®

An introduction to Neuropad® for healthcare professionals

Latest news and updates

New Barbie doll with type 1 diabetes

Mattel has introduced its first Barbie doll with type 1 diabetes, developed in collaboration with the nonprofit Breakthrough T1D. This…
Read More

Why is neuropathic pain worse at night?

Peripheral neuropathy-when nerves outside your brain and spinal cord misfire-often feels worse at night, disrupting sleep and amplifying pain, says…
Read More

Diabetes UK publishes response to the Government’s 10-year plan

Diabetes UK warmly welcomed the government’s July 3, 2025 release of its 10‑Year Health Plan for England, which prioritises shifting care closer…
Read More

Dutch study reveals that lab-grown cells may provide a potential cure for severe type 1 diabetes.

Dutch researchers have made a major breakthrough in treating severe type 1 diabetes by using lab-grown insulin-producing cells derived from…
Read More

Doctors are now permitted to prescribe weight loss injections, but only within specific guidelines.

GPs in England can now prescribe Mounjaro weight loss injections to adults who meet strict NHS criteria. Eligible patients must…
Read More

Groundbreaking research on diabetic neuropathy and nageotte nodules

Recent research from the University of Texas at Dallas’ Center for Advanced Pain Studies (CAPS) has revisited a phenomenon identified…
Read More

International Diabetes Federation officially recognises “type 5 diabetes”

On April 9, 2025, the International Diabetes Federation officially recognised “type 5 diabetes,” a form of malnutrition-related diabetes affecting millions…
Read More

Neuropad® reveals sudomotor decline linked to blood sugar and metabolic health

The study “Neuropad® assessment of sudomotor function across glycaemic levels in adults” undertaken by the Department of Endocrinology, The First…
Read More

Prevention in healthcare: turning words into action

The phrase “prevention is better than cure” remains largely unfulfilled in the UK, despite government efforts to shift the NHS…
Read More

Dapagliflozin promotes small nerve fibre regeneration in diabetic peripheral neuropathy

A recent study has identified that the sodium-glucose cotransporter 2 inhibitor dapagliflozin, a medicine used to treat type 2 diabetes,…
Read More

Do you have any questions?
Feel free to contact us anytime.